Works by VON DEPKA, M.

Results: 17

Factor VIII Inhibitor‐Tests Could Be Less Sensitive Than Supposed.

Published in:

Vox Sanguinis, 1999, v. 77, p. 87, doi. 10.1111/j.1423-0410.1999.tb00023.x

By:

Bartheis, M.;
Kraus, M.;
Bohn, U.;
Liese, B.;
von Depka, M.;
Eisert, R.;
Ganser, A.

Publication type:

Article

Factor VIII Inhibitor-Tests Could Be Less Sensitive Than Supposed.

Published in:

Vox Sanguinis, 1999, v. 77, p. 87, doi. 10.1159/000056725

By:

Barthels, M.;
Kraus, M.;
Bohn, U.;
Liese, B.;
von Depka, M.;
Eisert, R.;
Ganser, A.

Publication type:

Article

Diagnostic potential and limitations of thrombelastography/-metry.

Published in:

2007

By:

Lang T;
von Depka M

Publication type:

Journal Article

The Role of Factor XIII Val34Leu Polymorphism in Thrombotic Disease.

Published in:

Journal of Laboratory Medicine / Laboratoriums Medizin, 2001, v. 25, n. 7/8, p. 254

By:

Ehrenforth, Silke;
von Depka, M.

Publication type:

Article

Potentielle genetische Polymorphismen der venösen Thromboembolic.

Published in:

Journal of Laboratory Medicine / Laboratoriums Medizin, 2001, v. 25, n. 7/8, p. 277

By:

von Depka, M.;
Ehrenforth, Silke

Publication type:

Article

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

Published in:

Haemophilia, 2010, v. 16, n. 5, p. 747, doi. 10.1111/j.1365-2516.2010.02231.x

By:

ASTERMARK, J.;
ALTISENT, C.;
BATOROVA, A.;
DINIZ, M. J.;
GRINGERI, A.;
HOLME, P. A.;
KARAFOULIDOU, A.;
LOPEZ-FERNÁNDEZ, M. F.;
REIPERT, B. M.;
ROCINO, A.;
SCHIAVONI, M.;
von DEPKA, M.;
WINDYGA, J.;
FIJNVANDRAAT, K.

Publication type:

Article

European curriculum for thrombosis and haemostasis.

Published in:

Haemophilia, 2009, v. 15, n. 1, p. 337, doi. 10.1111/j.1365-2516.2008.01836.x

By:

ASTERMARK, J.;
NEGRIER, C.;
HERMANS, C.;
HOLME, P. A.;
KLAMROTH, R.;
KOTSI, P.;
DE MOERLOOSE, P.;
PASI, J.;
ROCINO, A.;
VON DEPKA, M.;
WINDYGA, J.;
LUDLAM, C. A.

Publication type:

Article

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.

Published in:

Haemophilia, 2007, v. 13, n. 1, p. 38, doi. 10.1111/j.1365-2516.2006.01403.x

By:

ASTERMARK, J.;
ROCINO, A.;
VON DEPKA, M.;
VAN DEN BERG, H. M.;
GRINGERI, A.;
MANTOVANI, L. G.;
MORADO, M.;
GARRIDO, R. P.;
SCHIAVONI, M.;
VILLAR, A.;
WINDYGA, J.

Publication type:

Article

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

Published in:

Haemophilia, 2006, v. 12, n. 4, p. 363, doi. 10.1111/j.1365-2516.2006.01296.x

By:

Astermark, J.;
Morado, M.;
Rocino, A.;
Van Den Berg, H. M.;
Von Depka, M.;
Gringeri, A.;
Mantovani, L.;
Garrido, R. P.;
Schiavoni, M.;
Villar, A.;
Windyga, J.

Publication type:

Article

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.

Published in:

Haemophilia, 2005, v. 11, p. 18, doi. 10.1111/j.1365-2516.2005.01157.x

By:

von Depka, M.

Publication type:

Article

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.

Published in:

Haemophilia, 2005, v. 11, p. 18, doi. 10.1111/j.1365-2516.2005.01157.x

By:

Von Depka, M.

Publication type:

Article

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.

Published in:

Haemophilia, 2004, v. 10, n. 5, p. 499, doi. 10.1111/j.1365-2516.2004.00950.x

By:

Auerswald, G.;
Prondzinski, M. Von Depka;
Ehlken, B.;
Kreuz, W.;
Kurnik, K.;
Lenk, H.;
Scharrer, I.;
Schramm, W.;
Zimmermann, R.

Publication type:

Article

Fifth Åland Island conference on von Willebrand disease.

Published in:

Haemophilia, 2018, v. 24, p. 5, doi. 10.1111/hae.13475

By:

Berntorp, E.;
Ågren, A.;
Aledort, L.;
Blombäck, M.;
Cnossen, M. H.;
Croteau, S. E.;
von Depka, M.;
Federici, A. B.;
Goodeve, A.;
Goudemand, J.;
Mannucci, P. M.;
Mourik, M.;
Önundarson, P. T.;
Rodeghiero, F.;
Szántó, T.;
Windyga, J.

Publication type:

Article

Efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures.

Published in:

Haemophilia, 2018, v. 24, n. 1, p. 70, doi. 10.1111/hae.13351

By:

Zozulya, N.;
Kessler, C. M.;
Klukowska, A.;
von Depka, M.;
Hampton, K.;
Hay, C. R. M.;
Jansen, M.;
Bichler, J.;
Knaub, S.;
Rangarajan, S.

Publication type:

Article

Canine hemophilia A caused by a mutation leading to a stop codon.

Published in:

Veterinary Record: Journal of the British Veterinary Association, 2011, v. 169, n. 19, p. 496, doi. 10.1136/vr.d4677

By:

Mischke, R.;
Wilhelm, Ch.;
Czwalinna, A.;
Varvenne, M.;
Narten, K.;
von Depka, M.

Publication type:

Article

Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.

Published in:

Gene Therapy, 2003, v. 10, n. 22, p. 1917, doi. 10.1038/sj.gt.3302093

By:

Tiede, A.;
Eder, M.;
von Depka, M.;
Battmer, K.;
Luther, S.;
Kiem, H-P.;
Ganser, A.;
Scherr, M.

Publication type:

Article

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature.

Published in:

2009

By:

Salama, A.;
Rieke, M.;
Kiesewetter, H.;
Depka, M.;
von Depka, M

Publication type:

journal article